Dystonia caused by ANO3 variants is due to attenuated Ca2+ influx by ORAI1

BMC Med. 2025 Jan 7;23(1):12. doi: 10.1186/s12916-024-03839-5.

Abstract

Background: Dystonia is a common neurological hyperkinetic movement disorder that can be caused by mutations in anoctamin 3 (ANO3, TMEM16C), a phospholipid scramblase and ion channel. We previously reported patients that were heterozygous for the ANO3 variants S651N, V561L, A599D and S651N, which cause dystonia by unknown mechanisms.

Methods: We applied electrophysiology, Ca2+ measurements and cell biological methods to analyze the molecular mechanisms that lead to aberrant intracellular Ca2+ signals and defective activation of K+ channels in patients heterozygous for the ANO3 variants.

Results: Upon expression, emptying of the endoplasmic reticulum Ca2+ store (store release) and particularly store-operated Ca2+ entry (SOCE) were strongly inhibited, leading to impaired activation of KCa3.1 (KCNN) K+ channels, but not of Na+-activated K+ channels (KNa; SLO2). The data provide evidence for a strongly impaired expression of store-operated ORAI1 Ca2+ influx channels in the plasma membrane of cells expressing ANO3 variants.

Conclusions: Dysregulated Ca2+ signaling by ANO3 variants may impair the activation of K+ channels in striatal neurons of the brain, thereby causing dystonia. Furthermore, the data provide a first indication of a possible regulation of protein expression in the plasma membrane by ANO3, as has been described for other anoctamins.

Keywords: ANO3; Anoctamin 3; Ca2+ signaling; Dystonia; K+ channels; TMEM16C.

MeSH terms

  • Anoctamins* / genetics
  • Anoctamins* / metabolism
  • Calcium* / metabolism
  • Dystonia* / genetics
  • Dystonia* / metabolism
  • HEK293 Cells
  • Humans
  • ORAI1 Protein* / genetics
  • ORAI1 Protein* / metabolism

Substances

  • Anoctamins
  • Calcium
  • ORAI1 Protein
  • ANO3 protein, human
  • ORAI1 protein, human